Shanghai
China
4
2023-02-21
4
2023-02-21
These are the the leading inventors for applications assigned to Eccogene (Shanghai) Co., Ltd.:
Eccogene (Shanghai) Co., Ltd. based in Shanghai, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Substituted imidazoles as GLP-1 receptor agonists
#2 | 2023-01-26 ✅ Patent 11,964,942 granted on 2024-04-23SSAO inhibitors and use thereof
#3 | 2021-07-29 ✅ Patent 11,780,825 granted on 2023-10-10Thyroid hormone receptor agonists and use thereof
#4 | 2021-05-20 ✅ Patent 11,472,769 granted on 2022-10-18SSAO inhibitors and use thereof
Also check out Eccogene (Shanghai) Co., Ltd.'s (Shanghai, China) applicant profile with 5 patent applications submitted.
388276 ⎘